Controlled release combination of carbidopa/levodopa
作者： Scott A. Reines , Donald W. Nibbelink , Edward C. Scholtz , Robert E. Dempski
DOI:
关键词: Over treatment 、 Carbidopa/levodopa 、 Controlled release 、 Pharmacology 、 Levodopa 、 Carbidopa 、 Drug 、 Chemistry 、 Drug delivery
摘要: A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists two drugs uniformly dispersed in a polymer vehicle at concentration that is greater than solubility either polymer. Treatment parkinsonism with formulation provides several advantages over treatment standard carbidopa/levodopa combinations presently employed.
google.com.mx参考文章(42)
Donald R. Holland, Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane ,(1980)
Jonas P. Uvdal, Eva C. Eskilsson, Curt H. Appelgren, Process for preparing rapidly disintegrating granulates ,(1987)
Kenneth J. Himmelstein, Gaylen M. Zentner, Gerald S. Rork, Multiparticulate controlled porosity osmotic ,(1987)
Takeru Higuchi, Toshiaki Nishihata, An orally administered drug form comprising a polar bioactive agent and an adjuvant ,(1981)
Robert E. Dempski, Gunvant N. Mehta, Joseph C. Saboe, Sustained release indomethacin ,(1978)
Peter Houmoeller, Helle Bechgaard, Pharmaceutical multiple-units formulation ,(1982)
Karl F. Mueller, Sonia J. Heiber, Membrane modified hydrogels ,(1980)
Felix Theeuwes, Brian L. Barclay, Patrick S.-L. Wong, Joseph C. Oeters, Osmotic system comprising plurality of members for dispensing drug ,(1986)